Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors

被引：0

作者：

Annemiek van Ommen-Nijhof

Judy N. Jacobse

Lars C. Steggink

Joop D. Lefrandt

Jourik A. Gietema

Flora E. van Leeuwen

Michael Schaapveld

Gabe S. Sonke

机构：

[1] The Netherlands Cancer Institute,Department of Medical Oncology

[2] Leiden University Medical Center,Department of Radiotherapy

[3] Erasmus University Medical Center,Department of Medical Oncology

[4] University Medical Center Groningen,Department of Internal Medicine

[5] University Medical Center Groningen,Department of Medical Oncology

[6] The Netherlands Cancer Institute,Department of Psychosocial Research and Epidemiology

[7] The Netherlands Cancer Institute,Department of Medical Oncology

[8] University of Amsterdam,Department of Medical Oncology

来源：

Breast Cancer Research and Treatment | 2022年 / 196卷

关键词：

Breast cancer; Endocrine therapy; Aromatase inhibitor; Cardiovascular disease;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：591 / 602

页数：11

共 50 条

[21] The Influence of Stress Management Interventions on Cardiovascular Disease Prevention During Aromatase Inhibitor Therapy for Breast Cancer
Merriman, John
Washington, Ashley
NURSING RESEARCH, 2022, 71 (03) : S71 - S72
[22] The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women
Mouridsen, HT
Robert, NJ
EUROPEAN JOURNAL OF CANCER, 2005, 41 (12) : 1678 - 1689
[23] Aromatase Inhibitor Adjuvant Chemotherapy of Breast Cancer Results in Cancer Therapy Induced Bone Loss
Renee Z. Rinaldi
Current Osteoporosis Reports, 2013, 11 : 61 - 64
[24] Aromatase Inhibitor Adjuvant Chemotherapy of Breast Cancer Results in Cancer Therapy Induced Bone Loss
Rinaldi, Renee Z.
CURRENT OSTEOPOROSIS REPORTS, 2013, 11 (01): : 61 - 64
[25] Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer
Kudchadkar, R
O'Regan, RM
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (03) : 145 - 163
[26] Vitamin D Insufficiency and Musculoskeletal Symptoms in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Waltman, Nancy L.
Ott, Carol D.
Twiss, Janice J.
Gross, Gloria J.
Lindsey, Ada M.
CANCER NURSING, 2009, 32 (02) : 143 - 150
[27] Combination of GnRH analogue and aromatase inhibitor as an adjuvant therapy in premenopausal nonmetastatic breast cancer
Modiramani, O.
Najafizadehgan, N.
Elahi, F.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[28] Enhancing skin appearance and quality of life in breast cancer survivors on aromatase inhibitor therapy
Cornell, Lauren
Tolaymat, Leila
Advani, Pooja
Chumsri, Saranya
Thais, Pincelli
CANCER RESEARCH, 2024, 84 (09)
[29] Understanding premature discontinuation of aromatase inhibitor (AI) therapy in postmenopausal breast cancer survivors
Stricker, C. T.
Palmer, S. C.
DeMichele, A.
Mao, J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[30] Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy
Ott, C. D.
Waltman, N. L.
Twiss, J. J.
BONE, 2007, 40 (06) : S310 - S310

← 1 2 3 4 5 →